Ammonium Tetrathiomolybdate
Generic Name: ammonium tetrathiomolybdate
Dosage form: POWDER. Active ingredients: TIOMOLIBDATE DIAMMONIUM (25 g/25g). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: TIOMOLIBDATE DIAMMONIUM (25 g/25g). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Antimonium Tartaricum, Arsenicum Album, Bryonia (alba), Echinacea (angustifolia), Gelsemium Sempervirens, Hepar Suis, Histaminum Hydrochloricum, Hyoscyamus Niger, Influenzinum, Ledum Palustre, Mercurius Solubilis, Mezereum, Nicotinamidum, Human Coronavirus (rna), Senega Officinalis, Silicea, Spigelia Anthelmia, Sulphur, Thuja Occidentalis, Zincum Metallicum
antimonium tartaricum, arsenicum album, bryonia (alba), echinacea (angustifolia), gelsemium sempervirens, hepar suis, histaminum hydrochloricum, hyoscyamus niger, influenzinum, ledum palustre, mercurius solubilis, mezereum, nicotinamidum, human coronavirus (rna), senega officinalis, silicea, spigelia anthelmia, sulphur, thuja occidentalis, zincum metallicum
PURPOSE: Antimonium Tartaricum - Headache, Arsenicum Album - Tiredness, Bryonia (Alba) – Sore Muscles, Echinacea (Angustifolia) - Headache, Gelsemium Sempervirens - Tiredness, Hepar Suis - Tiredness, Histaminum Hydrochloricum - Tiredness, Hyoscyamus Niger – Sore Muscles, Influenzinum - Tiredness, Ledum Palustre – Sore Muscles, Mercurius Solubilis - Tiredness, Mezereum - Headache, Nicotinamidum - Tiredness, RNA – Sore Muscles, Senega Officinalis - Tiredness, Silicea - Tiredness, Spigelia Anthelmi
Bevacizumab-bvzr
bevacizumab-bvzr
Vascular Endothelial Growth Factor Inhibitor [EPC]
11 DESCRIPTION Bevacizumab-bvzr is a vascular endothelial growth factor inhibitor. Bevacizumab-bvzr is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-bvzr has an approximate molecular weight of 149 kDa. Bevacizumab-bvzr is produced in a mammalian cell (Chinese Hamster Ovary) expression system.
Antihemophilic Factor (recombinant), Glycopegylated-exei
antihemophilic factor (recombinant), glycopegylated-exei
Dosage form: KIT. Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.